MT. LAUREL, N.J., (PRWEB) May 05, 2016
The 2016 PBIRG Annual General Meeting (AGM) is the must-attend event for professionals involved in global healthcare market research, being held May 15-17 in Boca Raton, FL.
Celebrating its 55th annual meeting, PBIRG, the Pharmaceutical Business Intelligence and Research Group, is a not-for-profit industry association dedicated to the advancement of global healthcare market research, business intelligence, and strategic planning in theory and practice.
“This year’s meeting will focus on understanding the needs of the complex patient,” said PBIRG president, Kai Bode of Merck. “The interactive workshops and educational sessions will challenge attendees to think differently about complex patients, markets, and technologies.”
The 2016 event will feature:
•Two pre-conference sessions
•21 university sessions covering three customized tracks: Complex Data for the Complex Patient, Beyond Pharma, and Thinking Beyond the Disease
•Interactive panel discussions
•Networking opportunities for attendees to share knowledge, experience, and exchange ideas focused on advancing market research practices within the global healthcare industry.
Keynote Speaker Erich Joachimsthaler, founder of Vivaldi Partners, a firm focusing on developing breakthrough innovation as well as growth and marketing strategies, will share his insight into how events of 2016 will shape the future of the healthcare industry while discussing the importance of market research and brand strategy.
“The AGM is the perfect opportunity for professionals to come together and learn from leaders in the industry,” added Bode. “To find out what’s next and discover meaningful, innovative approaches that are being leveraged in other organizations and across the industry.”
To view the program and learn more about PBIRG, visit http://www.pbirg.com and connect with PBIRG on Twitter by following @PBIRG.
Founded in 1961, PBIRG is dedicated to providing education and training to enhance members’ knowledge and skills, promoting and enhancing the image of the market research and business intelligence disciplines by providing guidance on ethical issues and serving as a liaison with pharmaceutical, biotechnology, diagnostic, and medical device companies as well as with marketing research agencies and associations.